How have recent FDA approvals for Edwards Lifesciences and Abbott changed patient care? Andrew Rassi, MD, answered that question—and many more—in a new interview. 

The PREVENT study, presented at ACC.24, examined more than 1,600 patients with high-risk plaques treated with either preventive PCI or medical therapy alone. Outcomes were much better for the PCI group after two years, but the findings may lead to more questions than answers. 

Interventional cardiologist Foluso Fakorede, MD, opened a practice in rural Mississippi, the epicenter of the PAD and CLI epidemic, to try and reverse the glaring health disparities in that region.

This recall is due to reports of “increased resistance” when using the devices. There have been 194 customer complaints about the issue so far. 

HeartFlow hopes to gather real-world data from up to 10,000 patients with suspected CAD.

New research explored the potential savings of turning off angiography systems at night and on weekends.

More than 100 patients have been seriously injured as a result of a significant safety concern. The Impella devices can still be used, according to the recall, if customers refer to Abiomed's new and revised instructions for use.

Kumar Madassery, MD, detailed some of the techniques and tools used to restore blood flow to the foot to help foot wounds heal and prevent amputation.